InvestorsHub Logo
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

Re: andrius post# 29370

Friday, 01/05/2018 1:22:18 AM

Friday, January 05, 2018 1:22:18 AM

Post# of 50155
Ending the previous agreements with the note holders not only gave DCTH access to their cash that was on hold, it also removed the "liens" on their patents and any tangible asssets they had that could be sold in lieu for repayment of the notes. The fact that the company was able to remove those restrictions was tremendous to say the least. Now pending Phase 3 results that we can only speculate will be good...based on current European Sentiments, will allow the company to go to the bargaining table with all their cards to play. No restrictions from outside entities. 300-700 million shares or not, a buyout will take into consideration all outstanding shares and all warrants. Even if they partner, share count won't matter either because there will be a huge upfront payment, and institutional investors will swoop in just as soon as the market cap goes up and the up list to NASDAQ takes place again.Float will be devoured, no matter what the number!
Cancer treatments and cancer drugs are high on all Big Pharma lists, and I assure you BP will want a piece of this before they get to a FDA approval. I expect the offers to start coming in as soon as the data is released!
IMHO OF COURSE!

In My Own Personal Opinion Of Course!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News